Singapore’s Biobot Surgical raises US$15.6M to take prostate-care robot global
Singapore-based medtech company Biobot Surgical has raised SGD 20 million (about US$15.6 million) in a financing round led by ClavystBio, with participation from ZIG Ventures, as it looks to expand global adoption of its robotic-assisted prostate cancer care platform and enter the US market. The…
No discussion yet. Be the first to share your thoughts!